SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-20-012337
Filing Date
2020-08-10
Accepted
2020-08-10 16:14:19
Documents
95
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q akba-20200630.htm   iXBRL 10-Q 3289681
2 EX-10.1 exhibit101.htm EX-10.1 25265
3 EX-10.2 exhibit102.htm EX-10.2 195465
4 EX-31.1 exhibit311.htm EX-31.1 13784
5 EX-31.2 exhibit312.htm EX-31.2 13807
6 EX-32.1 exhibit321.htm EX-32.1 12710
12 image11.jpg GRAPHIC 913
  Complete submission text file 0001628280-20-012337.txt   14127783

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT akba-20200630.xsd EX-101.SCH 99209
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT akba-20200630_cal.xml EX-101.CAL 152046
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT akba-20200630_def.xml EX-101.DEF 483924
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT akba-20200630_lab.xml EX-101.LAB 973973
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT akba-20200630_pre.xml EX-101.PRE 660471
13 EXTRACTED XBRL INSTANCE DOCUMENT akba-20200630_htm.xml XML 2564421
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36352 | Film No.: 201089525
SIC: 2834 Pharmaceutical Preparations